Chong Sun
Molecular Biology · Nature · 2012–2018
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 34 citations into it
Whom Chong Sun trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Chong Sun's perspective
Ordered by how strongly the researchers Chong Sun trusts endorse each paper. Same corpus, a different order for every researcher.
- The Protein Kinase Complement of the Human Genome (Science)
- Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)
- The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Nature Medicine)
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)
Their papers
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma (2014) — 815 citations
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR (2012) — 1,935 citations
- Regulation and Function of the PD-L1 Checkpoint (2018) — 1,861 citations
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators (2017) — 631 citations